Page 166 - Read Online
P. 166

alone, and excellent clustering was observed with   RT-PCR and -1.03 in TCGA). The raw expression data
            only two misclassifications [Supplementary Figure 3].   of 8 miRNAs were showed in Supplementary Table 4.
            Percentages of correctly classified HCC tissues were
            96% and 99% for the 48 paired and 302 unpaired tumor   Aberrant miRNAs panels associated with etiology-
            tissues respectively [Table 2], suggesting the promise   specific HCC
            of aberrantly expressed miRNAs as HCC biomarkers.  Subgroup analyses  for three  HCC-specific  major
                                                               etiologic  factors  (alcohol  abuse,  HBV  and  HCV
            We validated the  findings  from TCGA data by      infection)  by  two-sample  t-tests,  we  identified  4
            measuring miRNA profiles in 32 paired HCC tissues   upregulated (miR-10b, miR-21, miR-500a and miR-532)
            from CUMC. We observed 40 miRNAs  significantly    and 8  downregulated  miRNAs  panel significantly
            deregulated in HCC tumors (P < 0.05) with over 2-fold   associated with alcohol-related HCC [Table 3,
            changes [Supplementary  Figure  4], and 14 (let-7c,   Supplementary Figure 5A]. The 12-miRNAs panel
            miR-21, miR-99a, miR-125b, miR-130a, miR-139, miR-  can  distinguish alcohol-related HCC tumor from
            144, miR-145, miR-150, miR-199a, miR-223, miR-378,   non-tumor with 3 misclassifications [Supplementary
            miR-455 and miR-486) overlap with those identified   Figure 5B]. There were panels of 7 and 4 significant
            in  TCGA data. Eight  miRNAs  (miR-122, miR-1180,   aberrantly expressed miRNAs  observed in HBV- or
            miR-199a, miR-182, miR-152, miR-125b, miR-18a and   HCV-related HCC,  respectively,  with  over 2-fold
            miR-10a) with various expression levels in TCGA data   expression changes [Table 3, Supplementary Figure 6].
            were randomly selected and evaluated by TaqMan     These miRNA panels can also correctly classify HBV-
            quantitative reverse transcription polymerase chain   or HCV-infected tumors with 1-2 misclassifications
            reaction (RT-PCR) in 66 paired HCC tissues  from   [Supplementary Figure 7]. Comparison of significant
            CUMC. Seven out of 8 miRNAs had consistent fold-   miRNAs for HCCs with different etiologies and overall
            changes as in TCGA data [Supplementary Table 3]. Only   HCCs, only miR-424 was consistently down-regulated
            miR-152 showed an inconsistent fold-change (1.01 in   among all HCC groups; miR-6b was only significantly








































            Figure 2: Hepatocellular carcinoma (HCC) “tumor specific” miRNA expression patterns (fold-changes and standard errors) compared to 8 other types of solid
            tumors. Three miRNAs (miR-24-1, miR-130a and miR-505) were significantly down-regulated in HCC with over 2-fold changes. Although the expression pattern
            of 3 miRNAs was consistently repressed in kidney renal cell carcinoma (KIRC) and prostate adenocarcinoma (PRAD), none were statistically significant. An up-
            regulated expression pattern was observed for the 3 miRNAs in head and neck squamous cell carcinoma (HNSC), lung adenocarcinoma (LUAD) and stomach
            adenocarcinoma (STAD), but also no significant difference. Both up- and down-regulation patterns were obtained for the 3 miRNAs in female breast invasive
            carcinoma (BRCA), lung squamous cell carcinoma (LUSC) and thyroid carcinoma (THCA), suggesting their tumor specificity


                 Hepatoma Research | Volume 2 | June 1, 2016                                              157
   161   162   163   164   165   166   167   168   169   170   171